Navigation Links
Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
Date:2/6/2013

of its revenue from Neupogen franchise. However, the drug would go off patent protection by the end of 2013 and the loss of exclusivity is expected to affect Amgen. Neupogen faces stiff competition from the companies like Novartis in the markets outside of the U.S. and these competing companies may launch their products in the U.S., causing further damage. However, the company has somewhat strong drug candidates including AMG145, a cholesterol drug candidate.

Amgen stock grew over 25 percent in the past 12 months. It also offers good dividend yield of 2.17 percent. The company is likely to increase its dividend in the future, thus offering good returns to the investors. Amgen is also growing through acquisitions as it recently completed the purchase of Icelandic company decode Genetics.

Peregrine Struggles with Cancer Drug Development

Peregrine Pharmaceuticals Inc. specializes in developing therapies for viral infections. It also develops treatments for cancers. It is currently engaged in developing treatment for non-small cell lung cancer. If successful, the company will make big fortunes as non-small cell lung cancer accounts for about 80 percent of lung cancer cases. However, the company does not have very solid track record. The drug candidate bavituximab has been controversial as it led to the stock's massive tumble in September 2012. Sign up to download the free technical analysis on Peregrine Pharmaceuticals at

http://www.StockCall.com/PPHM020613.pdf  

Peregrine is a small company with the market capitalization of less than $300 million. The stock is quite volatile as well. The company is currently looking to get past the phase II for bavituximab. Overall, the stock may be held if it is already in your portfolio. On the upside, the stock is currently trading about 50 percent below its 52-week high, thus in case of positive news on its
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 /CNW/ - ChipCare Corporation, a ... blood-testing platform for HIV and other infectious and ... A financing to bring its first-generation product to ... products. (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ) ... settings to simple, accurate and affordable diagnostic tests ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... PharmaBiotech,s new report "Cardiovascular Drug Delivery - Technologies, ... Drug delivery to the cardiovascular system is ... anatomy and physiology of the vascular system; it supplies ... Drugs can be introduced into the vascular system for ...
(Date:3/3/2015)... DENVER , March 3, 2015  Tru-D ... at the Association for Perioperative Registered Nurses, Surgical ... Colorado , during Patient Safety Awareness Week ... with resources for safe clinical practice and professional ...   Photo - http://photos.prnewswire.com/prnh/20150302/178998LOGO   ...
Breaking Medicine Technology:ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3
... N.J., Dec. 13, 2010 PharmaNet Development Group, ... to pharmaceutical, biotechnology, generic drug and medical device ... launching two technology platforms – Initiator™ and PKS™ ... study timelines by accelerating data acquisition and the ...
... MedShape Solutions, Inc., the world,s leading developer of ... today announced a strategic investment and development agreement ... identifies innovative technology solutions to support the missions ... MedShape,s business is built on a technology platform ...
Cached Medicine Technology:PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics 2PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics 3MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community 2
(Date:3/3/2015)... Aliso Viejo, California (PRWEB) March 03, 2015 ... new animated effect entitled inMotion3D Environment from Pixel Film ... turns a 2D HDRI image into 360° viewing area ... Film Studios. “inMotion3D Environment blurs the line between professional ... , Motion 5 users can turn their 2D HDRI ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Aureus Medical ... including Physician jobs, has announced that it will participate ... be held Tuesday, March 17, 2015 in St. Louis, ... opportunity to meet job-seeking residents and fellows in a ... physician division will be available to speak with ...
(Date:3/3/2015)... Aliso Viejo, California (PRWEB) March 03, 2015 ... Studios have announced the release of a new plugin ... , “FCPX3D Confetti animates an exploding transition using confetti ... Film Studios. “When adding an FCPX3D Confetti transition, users ... this FCPX Plugin.” , Transition from one clip to ...
(Date:3/2/2015)... 2015 Formetco today announced the official ... The FTX uses state-of-the-art technology to deliver an outdoor ... owner satisfaction. An item of particular value, and ... 10 year LED Brightness Warranty. , Why the FTX ... superior billboard among any other billboard product in the ...
(Date:3/2/2015)... Boston/Framingham (PRWEB) March 02, 2015 Getting ... freezer section is the goal this March as the ... was designated by the National Frozen & Refrigerated Foods ... food offers. Ian’s offers more than 20 delicious frozen ... exciting month. , The tasty frozen options are crafted ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled inMotion3D Environment Was Released Today from Pixel Film Studios Exclusively for Motion 5 2Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2Health News:Formetco Launches Innovative LED Billboard System 2Health News:Take a Fresh Look at Frozen with Ian’s 2
... Binge drinking may not necessarily kill or even damage brain ... But it can block key receptors in the brain and ... critical to learning and memory, according to researchers. Neuroscientists ... their findings not only shed light on exactly what is ...
... Of 180 patients in this study in whom a ... had originally been misdiagnosed by their family doctors as ... colleagues present the results of their cross-sectional study in ... (Dtsch Arztebl Int 2011; 108[26]: 445-51). When a ...
... Misinformation about venomous spiders and spider bites often leads emergency ... creatures for "necrotic" skin lesions, new research indicates. Necrotic ... die due to a lack of blood and oxygen, and ... necrotic lesions on the skin are typically not the result ...
... patients and for the first time researchers have found ... heart failure outcomes, a highlight of the recent American ... was the need to establish the mechanisms by which ... Christopher S. Lee, PhD, RN of the Oregon ...
... July 13 (HealthDay News) -- Rural workers are often forced to ... and their jobs, researchers report. According to the study ... New Hampshire, people who work in rural communities have less access ... or lost jobs and caring for themselves or a family member ...
... that are designed to suppress the formation of new ... slowed cancer growth in some patients. However, they have ... might. Now, research from the Perelman School of Medicine ... the modest responses. The discovery, published in the July ...
Cached Medicine News:Health News:Rat Study Shows How Binge Drinking Harms Memory 2Health News:Skin Lesions Often Misdiagnosed as Spider Bites 2Health News:Heart failure: Doing what your doctor says works 2Health News:Rural Workers Often Lack Access to Sick Leave 2Health News:Penn study shows link between immune system suppression and blood vessel formation in tumors 2
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: